{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:54:40Z","timestamp":1787007280403,"version":"build-2736575974"},"reference-count":33,"publisher":"Informa UK Limited","issue":"11","license":[{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncology"],"published-print":{"date-parts":[[2026,5,3]]},"DOI":"10.1080\/14796694.2026.2662504","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T07:21:06Z","timestamp":1776928866000},"page":"1331-1340","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Real-world treatment patterns and outcomes of patients with multiple myeloma initiating elranatamab: results from the ALTITUDE-1 and ALTITUDE-2 retrospective cohort studies"],"prefix":"10.1080","volume":"22","author":[{"given":"Rahul","family":"Banerjee","sequence":"first","affiliation":[{"name":"Fred Hutchinson Cancer Center","place":["Seattle, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera","family":"Mohan","sequence":"additional","affiliation":[{"name":"Medical College of Wisconsin","place":["Milwaukee, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavesh","family":"Shah","sequence":"additional","affiliation":[{"name":"Boston Medical Center","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Prince","sequence":"additional","affiliation":[{"name":"Aetion","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nileesa","family":"Gautam","sequence":"additional","affiliation":[{"name":"Aetion","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisha","family":"Beebe","sequence":"additional","affiliation":[{"name":"Aetion","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Pajerowski","sequence":"additional","affiliation":[{"name":"Clarify Health","place":["San Francisco, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cera","family":"Cantu","sequence":"additional","affiliation":[{"name":"Clarify Health","place":["San Francisco, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Meiseles","sequence":"additional","affiliation":[{"name":"Clarify Health","place":["San Francisco, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hughes","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["Cambridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Nador","sequence":"additional","affiliation":[{"name":"Pfizer Ltd","place":["Surrey, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rickard","family":"Sandin","sequence":"additional","affiliation":[{"name":"Pfizer AB","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Hlavacek","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Li","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aster","family":"Meche","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chai","family":"Hyun Kim","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Perez Cruz","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsena","family":"Sumaya","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"DiBonaventura","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"key":"e_1_3_7_3_1","volume-title":"StatPearls","author":"Albagoush SA","year":"2024","unstructured":"Albagoush SA, Shumway C, Azevedo AM. StatPearls. Treasure Island, FL, USA: StatPearls Publishing; 2024. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK534764\/"},{"key":"e_1_3_7_4_1","unstructured":"Myeloma - cancer stat facts. SEER; 2025. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/mulmy.html"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-116129"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.183475"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020407"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2016-0104"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00043-3"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.70067"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.0003"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2026.0001"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02528-9"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.136"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-208192"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2025-136"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2025-4045"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2025-4588"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2021-0618"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2022-1018"},{"key":"e_1_3_7_21_1","unstructured":"FDA. ELREXFIOTM (elranatamab-bcmm) injection for subcutaneous use initial U.S. approval: 2023. 2023. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/761345s000lbl.pdf"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.2147\/CEOR.S501404"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2023-0995"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.2147\/BLCTT.S516356"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-14624-9"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2023.2277850"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.e19507"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2025028383"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-200933"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00950-3"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.14348"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023022937"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2025.04.002"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-025-01254-4"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.7549"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2026.2662504","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T14:11:47Z","timestamp":1777903907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14796694.2026.2662504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,5,3]]}},"alternative-id":["10.1080\/14796694.2026.2662504"],"URL":"https:\/\/doi.org\/10.1080\/14796694.2026.2662504","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-01-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}